| CPC A61M 1/1698 (2013.01) [A61M 1/1603 (2014.02); A61M 1/3638 (2014.02); A61M 2205/3327 (2013.01); A61M 2205/3334 (2013.01); A61M 2230/202 (2013.01); A61M 2230/205 (2013.01)] | 8 Claims |

|
1. An artificial lung system for a patient, the system comprising:
a membrane lung system having an gas inlet, a blood inlet, a blood outlet, and an exhaust;
a gas system operably coupled to the gas inlet of the membrane lung system for introducing gas to the membrane lung system;
a gas phase CO2 sensor disposed downstream of the exhaust of the membrane lung system and monitoring an exhaust gas CO2 (EGCO2) level, the gas phase CO2 sensor outputting a CO2 signal in response to a detected EGCO2 level; and
a feedback controller receiving the CO2 signal and outputting an gas system control signal to the gas system responsive thereto such that if EGCO2 content increases relative to a target CO2 level, the feedback controller increases sweep flow of the gas system to remove more CO2 from the blood flowing through the blood inlet to the blood outlet, if EGCO2 content decreases relative to the target CO2 level, the feedback controller automatically decreases sweep flow of the gas system to reduce CO2 removal.
|